AAP
TMDX icon

Arax Advisory Partners’s Transmedics TMDX Stock Holding History

Arax Advisory Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.49K Buy
90
+21
+30% +$2.74K ﹤0.01% 2666
2025
Q4 		$8.39K Sell
69
-68
-50% -$8.53K ﹤0.01% 2563
2025
Q3 		$15.4K Buy
137
+43
+46% +$5.03K ﹤0.01% 2397
2025
Q2 		$12.6K Buy
94
+1
+1% +$110 ﹤0.01% 1864
2025
Q1 		$6.26K Buy
+93
New +$6.4K ﹤0.01% 1706

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arax Advisory Partners's TMDX Position: Q1 2026 in Review

Arax Advisory Partners increased its Transmedics (TMDX) stake by 30% in Q1 2026, buying an estimated $2.74K and bringing the position to 90 shares worth $6.49K. The position accounts for ﹤0.01% of the portfolio, ranked #2666.

Arax Advisory Partners first reported a position in TMDX in Q1 2025 and has held it in 5 quarters since. The position peaked at $15.4K in Q3 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Arax Advisory Partners held 90 shares of Transmedics worth $6.49K as of Q1 2026.
  • Arax Advisory Partners bought 21 Transmedics shares in Q1 2026, an estimated $2.74K.
  • Transmedics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #2666 holding.
  • Arax Advisory Partners first reported a position in Transmedics in Q1 2025 and has held it in 5 quarters since.
  • Arax Advisory Partners's Transmedics position peaked at $15.4K in Q3 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.